CRIOAc Lyon Posters

44th Annual Meeting of the European Bone and Joint Infection Society (EBJIS)
du 17/09/2026 au 19/09/2026
Porto - Portugal

Use of synthetic bone substitutes loaded with antibiotics in the management of three chronic infections on instrumented spine

Chronic infections on instrumented spine (CIIS) are complex and often require extensive management. When resection surgery is performed , it results in a dead space . The use of a bone substitute composed of hydroxyapatite and calcium sulfate loaded with gentamicin is routinely performed in our reference centre for the management of chronic cavitary osteomyelitis. We report here 3 cases

2026 - European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global)
du 17/04/2026 au 21/04/2026
Munich - Allemagne

Debridement, antibiotics, and implant retention (DAIR) followed by suppressive antimicrobial therapy (SAT)

Debridement, antibiotics, and implant retention (DAIR) followed by suppressive antimicrobial therapy (SAT) is a useful strategy in patients with biofilm-associated prosthetic joint infection (PJI) for whom prosthesis removal is not desirable

43th Annual Meeting of the European Bone and Joint Infection Society (EBJIS)
du 11/09/2025 au 13/09/2025
BOLOGNA, ITALY

Overview of Campylobacter spp. bone and joint infection in French reference centers

Efficacy and safety of dalbavancin as suppressive therapy

Peripheral neuropathy during long term therapy with tedizolid

2025 - European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global)
du 11/04/2025 au 15/04/2025
Vienne, Autriche

Preliminary safety and efficacy 12 weeks results of PhagoDAIR-I, a Pilot Study of Phage Therapy in Patients with Hip or Knee Prosthetic Joint Infection due to Staphylococcus aureus.

42th Annual Meeting of the European Bone and Joint Infection Society
du 26/09/2024 au 28/09/2024
BARCELONA, SPAIN

CIERNY AND MADER STAGE III ADULT LONG BONE CHRONIC OSTEOMYELITIS: RETROSPECTIVE STUDY AT THE LYON REFERENCE CENTRE FOR COMPLEX OSTEOARTICULAR INFECTIONS (CRIOAC)

TWO NEW LOCAL POTENTIAL WEAPONS AS ADJUVANT DURING DAIR STRATEGY IN CHRONIC PERIPROSTHETIC JOINT INFECTIONS (PJI): A SINGLE CENTER RETROSPECTIVE STUDY

25èmes Journées Nationales d’Infectiologie (JNI)
du 12/06/2024 au 14/06/2024
Deauville, France

Utilisation du STIMULAN® et du BACTISURE® dans les infections chroniques d’implants articulaires : une série rétrospective monocentrique

33th European Society of Clinical Microbiology and Infectious Diseases (ECCMID)
du 15/04/2023 au 18/04/2023
Copenhagen, Denmark

MULTICENTRE EVALUATION OF RAPID MOLECULAR SYNDROMIC APPROACH IN JOINT INFECTIONS USING A NEW DEDICATED PANEL : FILMARRAY® BIOFIRE® JOINT INFECTION

Diagnostic, management and outcome of bone flap osteomyelitis following craniectomy: a cohort study

Validation of a rabbit model of in vivo biofilm formation on beads for ex vivo evaluation of the antibiofilm activity of antistaphylococcal drugs

Risk factors, management and outcome of early (<6 months) open fracture-related infections (FRI)

9th Annual Meeting of the European Bone and Joint Infection Society
du 07/10/2021 au 09/10/2021
Ljubljana, Slovenia

CEFTAROLINE AND CEFTOBIPROLE: REAL LIFE OFF LABEL USE IN PATIENTS WITH BJI OF THESE TWO BETALACTAMS ACTIVE AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCI

IMPLEMENTATION OF A PHAGE THERAPY CENTER IN FRANCE DEDICATED TO COMPLEX BONE AND JOINT INFECTION: 4-YEAR EXPERIENCE OF MULTIDISCIPLINARITY AND MULTISTEP INTERACTIONS

21èmes Journées Nationales d'Infectiologie
du 30/08/2021 au 01/09/2021
Montpellier, France

Coût des antibiothérapies hors AMM dans les infections ostéo-articulaires : Etude prospective observationnelle sur 6 ans dans un Centre de Référence pour la prise en charge des IOA complexes (CRIOAc)

Projet PHAGEinLYON – Traitement par phagothérapie des infections ostéo-articulaires à staphylocoques: caractérisation de dix-sept bactériophages anti-Staphylococcus

Mise en place d’un centre de phagothérapie en France dédié aux infections ostéo-articulaires complexes : 4 ans d’expérience de multidisciplinarité et d’interactions multi-étapes

Conception et construction d’un bâtiment dédié aux maladies infectieuses et tropicales : huit années de travail concerté pour obtenir une structure innovante et modulable en fonction du risque épidémique

31th European Society of Clinical Microbiology and Infectious Diseases (ECCMID)
du 09/07/2021 au 12/07/2021
Virtual Event

Safety of tedizolid as suppressive antimicrobial therapy for patients with complex implant-associated bone and joint infection due to multidrug-resistant Gram-positive pathogens: results from the TediSAT cohort study

Implementation of a phage therapy center in France dedicated to complex bone and joint infection: 4-year experience of multidisciplinarity and multistep interactions

Isolation and characterization of a novel Jumbo phage active against the emerging ST307 carbapenemase-producing K. pneumoniae clone

Targeting coagulase negative staphylococci causing prosthetic infections with bacteriophages: can we use polyvalent anti Staphylococcus phages ?

Phage discovery: isolation and characterization of seventeen novel anti-Staphylococcus aureus bacteriophages

e-congres Société Française de Pharmacologie et de Thérapeutique
du 15/06/2021 au 16/06/2021
Virtual Event

Results of a collaboration between a CRPV and an infectious disease care service

30th European Society of Clinical Microbiology and Infectious Diseases (ECCMID)
du 18/04/2020 au 21/04/2020
Paris, France

Personalized production and administration of bacteriophages: lessons learned from a unique European academic collaboration to treat a patient with pandrug-resistant spinal P. aeruginosa infection

Intravenous administration of personalized cocktail of bacteriophages as salvage therapy in combination with ceftazidime/avibactam in patients with relapsing P. aeruginosa bacteremia associated with intravascular implants: Lesson to be learned from two cases

Ultrasound-guided local administration of personalized cocktail of bacteriophages followed by suppressive antibiotherapy as salvage therapy in patients with relapsing total femur prosthetic joint infection (PJI)

Arthroscopic Debridement Antibiotic And Implant Retention (DAIR) with local administration of Exebacase (Lysin CF-301) (LysinDAIR) followed by suppressive tedizolid as salvage therapy in elderly patients for relapsing multidrug-resistant Staphylococcus epidermidis prosthetic knee infection

40ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse (RICAI)
du 14/12/2020 au 15/12/2020
Virtual Event

Utilité du dithiothréitol pour diagnostiquer les infections sur prothèses ostéo articulaires

ISPOR Europe 2019
du 02/11/2019 au 06/11/2019
Copenhague, Danemark

Economic study of medico-surgical strategies in patients with chronic knee or hip prosthetic joint infection

IDWEEK : Infection Diseases Society of America (IDSA), 2019
du 02/10/2019 au 06/10/2019
Washington, USA

Comparison of tolerance and microbiological efficacy of cefepim and piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study

Purified personalized bacteriophages as part of salvage therapy in patients with complex BJI: A 2-year experience in a reference center in France

Impact on the gut microbiota of the prolonged antimicrobial therapy in patients with bone and joint infection (BJI): results from the OSIRIS prospective study in France

SFAR 2019
du 19/09/2019 au 21/09/2019
Paris, France

Rôle du médecin anesthésiste dans la prise en charge des reprises septiques d’arthroplasties de genou

38th Annual Meeting of the European Bone and Joint Infection Society
du 12/09/2019 au 14/09/2019
Anvers, Belgique

Tolerance and microbiological efficacy cefepim or piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of PJI

Purified personalized bacteriophages as part of salvage therapy in patients with complex BJI: A 2-year experience in a reference center in France

JOBIM 2019
du 02/07/2019 au 05/07/2019
Nantes, France

Whole metagenome analysis with metagWGS

23ème édition du Congrès de Société Française de Pharmacologie et de Thérapeutique
du 12/06/2019 au 14/06/2019
Lyon, France

Assessment of drug adherence to oral antibacterial therapy in bone and joint infections: a pilot study

Implementation and validation of a pharmacokinetic model for Bayesian therapeutic drug monitoring of daptomycin in patients with bone and joint infection

20èmes Journées Nationales d'Infectiologie
du 05/06/2019 au 07/06/2019
Lyon, France

Immunothérapie préventive par MEDI6389, combinaison d’anticorps monoclonaux antialpha- toxine, leucocidine de Panton-Valentin et ED, gamma-hémolysine et clumping facteur A dans un modèle lapin d’infection de prothèse articulaire à SARM USA300

Evaluation de l’efficacité d’un assemblage de trois bactériophages anti staphylococcus contre les bactéries au sein du biofilm ou internalisées dans les ostéoblastes

Effets anti-biofilm prophylactiques de ciments osseux chargés d’antibiotiques contre Staphylococcus aureus et Staphylococcus epidermidis

Observance au traitement antibiotique par voie orale dans les infections ostéo-articulaires : étude pilote

Pharmacocinétique de la daptomycine dans les infections ostéo-articulaires : intérêt du suivi thérapeutique pharmacologique et de l’individualisation posologique

229th ECCMID
du 13/04/2019 au 16/04/2019
Amsterdam, Pays-Bas

Pseudomonas aeruginosa implant-associated Bone and Joint Infections : Experience in a Regional Reference Center in France

Prophylactic anti-biofilm effects of antibiotic-loaded bone cements against Staphylococcus aureus and Staphylococcus epidermidis

Evaluation of the efficacy of an assembly of three bacteriophages compared or associated to antibiotics on Staphylococcus aureus embedded in biofilms or internalised in osteoblasts

39ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse (RICAI)
du 16/12/2019 au 17/12/2019

Infections ostéo-articulaire à S. aureus : activité intra-ostéoblastique et anti-biofilm des rifamycines

L’alcalinisation phagolysosomale dans le traitement des infections ostéo-articulairesà Staphylococcus aureus

Comparaison de deux modèles pharmacocinétiques pour le suivi thérapeutique de la daptomycine

IDWEEK : Infectious Diseases Society of America (IDSA), 3 - 7 octobre 2018,
du 03/10/2018 au 07/10/2018
San Francisco, USA

Staphylococcal acute post-operative prosthetic joint infection (PJI) treated with ‘DAIR’ (debridement and implant retention) and impact of rifampin: a retrospective cohort study in France

Congrès National de la Société Française de Microbiologie (SFM), 2018
du 01/10/2018 au 03/10/2018
Paris, France

Infections ostéo-articulaires : activité intra-ostéoblastique des rifamycines et oxazolidinones

37th annual meeting of the European Bone and Joint Infection Society (EBJIS)
du 06/09/2018 au 08/09/2018
Helsinki, Finlande

Salvage ‘DAIR’ (debridement, antibiotics and implant retention) with local injection of a selected mix of bacteriophages in an elderly patient with relapsing S. aureus prosthetic-joint infection

19èmes Journées Nationales d’infectiologie
du 13/06/2018 au 15/06/2018
Nantes, France

Activité de nouvelles molécules anti-staphylococciques sur la persistance intra-ostéoblastique

Infection de prothèse et changement en 1 temps : prétraitement par antibiothérapie ciblée chez des patients à risque

Capacité du linézolide et du tédizolide à éradiquer Staphylococcus aureus en intracellulaire et sous forme de biofilm au cours du traitement des infections ostéo-articulaires

Traitement des infections ostéo-articulaires à S. aureus : activité intra-ostéoblastiques des rifamycines et impact sur l’émergence intracellulaire de small colony variants

Evaluation de l’utilisation de la céfoxitine en association en administration parentérale continue dans le traitement des infections ostéo-articulaires

Infections chroniques sur prothèses articulaires (IPA) à Cutibacterium acnes diagnostiquées par PCR spécifique : une étude descriptive de 6 patients

ECCMID 2018
du 21/04/2018 au 24/04/2018
Madrid, Espagne

Interventional Study of Bone and Joint Infections related gut Dysbiosis (OSIRIS study): first results of a prospective multicenter trial

IDWEEK : Infectious Diseases Society of America (IDSA), 2017
du 04/10/2017 au 08/10/2017
San Diego, USA

Microbiological epidemiology in patients experiencing microbiological or clinical failure following reimplantation after a 2-stage exchange strategy for hip or knee prosthetic joint infection (PJI)

Pressure ulcer-related pelvic osteomyelitis : Evaluation of a two-stage surgical strategy (debridement, negative pressure therapy and flap coverage) with prolonged antimicrobial therapy

Microbiological epidemiology depending on time to occurrence of prosthetic joint infection (PJI) : impact on the empirical antimicrobial strategies

Pubic osteomyelitis (PO) : Epidemiology and factors associated with management failure in two French Reference Centers

Corynebacterium bone and joint infection (BJI): A retrospective cohort from a BJI reference center

Subcutaneous Suppressive Antibiotic Therapy for Bone and Joints Infections: Safety and Outcome in a Cohort of 10 Patients

36th Annual Meeting of the European Bone and Joint Infection Society
du 07/09/2017 au 09/09/2017
Nantes, France

Selection and local application of a cocktail of bacteriophages in addition with local colistin therapy and off-label use of ceftolozane/tazobactam for the treatment of a complex bone and joint infection due to multidrug-resistant P. aeruginosa

Cost of off-label antibiotic therapy in bone and joint infection (BJI) : prospective 2-year study in a complex BJI reference center

36ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse (RICAI)
du 12/12/2016 au 13/12/2016
Paris, France

Klebsiella pneumoniae réductrice de carbapenemases KPC : Activité bactéricide de six antibiotiques

Génériques du Méropénème et activité bactéricide sur souches KPC

Internalisation et persistance de Staphylococcus aureus au sein d’ostéoblastes humains

Biofilm : Adaptation in vivo des souches de S. aureus responsables d’IOA

Alere™ PBP2a SA Culture Colony Test : Evaluation de la nouvelle génération du test

35th Annual Meeting of the European Bone and Joint Infection Society (EBJIS)
du 01/09/2016 au 03/09/2016
Oxford, UK

Adaptation of the capacity to form biofilm in Staphylococcus aureus isolates during the course of human chronic bone and joint infections

Investigation of the ability to be internalized in osteoblasts as a pathophysiological mechanism involved in Staphylococcus non-aureus bone and joint infection

Pharmacokinetics of Ertapenem Administered by Intravenous or Subcutaneous Route in Patients with Bone and Joint Infections: Population and Monte Carlo simulation study

25th European Society of Clinical Microbiology and Infectious Diseases (ECCMID)
du 25/04/2015 au 28/04/2015
Copenhague, Danemark

Evidence of adaptative processes of Staphylococcus aureus isolates in the course of chronic bone and joint infections in patients

Management of P. acnes bone and joint infection in a regional reference centre in France

Periprosthetic knee infection due to Pasteurella multocida: the cat was guilty!

ICAAC, 2015
du 17/09/2015 au 21/09/2015
San Diego, USA

Autologous Bone Flap infection Following Craniectiomy: Clinical Experience in a Referral Center

16èmes Journées Nationales d’Infectiologie (JNI)
du 10/06/2015 au 12/06/2015
Lille, France

Antibiothérapie suppressive (ABS) dans les infections de prothèses ostéo-articulaires (IPOA) chez le patient âgé

2026

44th Annual Meeting of the European Bone and Joint Infection Society (EBJIS)du 17/09/2026 au 19/09/2026Porto - Portugal

2026 - European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global)du 17/04/2026 au 21/04/2026Munich - Allemagne

2025

43th Annual Meeting of the European Bone and Joint Infection Society (EBJIS)du 11/09/2025 au 13/09/2025BOLOGNA, ITALY

2025 - European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global)du 11/04/2025 au 15/04/2025Vienne, Autriche

2024

42th Annual Meeting of the European Bone and Joint Infection Societydu 26/09/2024 au 28/09/2024BARCELONA, SPAIN

25èmes Journées Nationales d’Infectiologie (JNI)du 12/06/2024 au 14/06/2024Deauville, France

2023

33th European Society of Clinical Microbiology and Infectious Diseases (ECCMID)du 15/04/2023 au 18/04/2023Copenhagen, Denmark

2021

9th Annual Meeting of the European Bone and Joint Infection Societydu 07/10/2021 au 09/10/2021Ljubljana, Slovenia

21èmes Journées Nationales d'Infectiologiedu 30/08/2021 au 01/09/2021Montpellier, France

31th European Society of Clinical Microbiology and Infectious Diseases (ECCMID)du 09/07/2021 au 12/07/2021Virtual Event

e-congres Société Française de Pharmacologie et de Thérapeutiquedu 15/06/2021 au 16/06/2021Virtual Event

2020

30th European Society of Clinical Microbiology and Infectious Diseases (ECCMID)du 18/04/2020 au 21/04/2020Paris, France

40ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse (RICAI)du 14/12/2020 au 15/12/2020Virtual Event

2019

ISPOR Europe 2019du 02/11/2019 au 06/11/2019Copenhague, Danemark

IDWEEK : Infection Diseases Society of America (IDSA), 2019du 02/10/2019 au 06/10/2019Washington, USA

SFAR 2019du 19/09/2019 au 21/09/2019Paris, France

38th Annual Meeting of the European Bone and Joint Infection Societydu 12/09/2019 au 14/09/2019Anvers, Belgique

JOBIM 2019du 02/07/2019 au 05/07/2019Nantes, France

23ème édition du Congrès de Société Française de Pharmacologie et de Thérapeutiquedu 12/06/2019 au 14/06/2019Lyon, France

20èmes Journées Nationales d'Infectiologiedu 05/06/2019 au 07/06/2019Lyon, France

229th ECCMIDdu 13/04/2019 au 16/04/2019Amsterdam, Pays-Bas

39ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse (RICAI)du 16/12/2019 au 17/12/2019

2018

IDWEEK : Infectious Diseases Society of America (IDSA), 3 - 7 octobre 2018,du 03/10/2018 au 07/10/2018San Francisco, USA

Congrès National de la Société Française de Microbiologie (SFM), 2018du 01/10/2018 au 03/10/2018Paris, France

37th annual meeting of the European Bone and Joint Infection Society (EBJIS)du 06/09/2018 au 08/09/2018Helsinki, Finlande

19èmes Journées Nationales d’infectiologiedu 13/06/2018 au 15/06/2018Nantes, France

ECCMID 2018du 21/04/2018 au 24/04/2018Madrid, Espagne

2017

IDWEEK : Infectious Diseases Society of America (IDSA), 2017du 04/10/2017 au 08/10/2017San Diego, USA

36th Annual Meeting of the European Bone and Joint Infection Societydu 07/09/2017 au 09/09/2017Nantes, France

2016

36ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse (RICAI)du 12/12/2016 au 13/12/2016Paris, France

35th Annual Meeting of the European Bone and Joint Infection Society (EBJIS)du 01/09/2016 au 03/09/2016Oxford, UK

2015

25th European Society of Clinical Microbiology and Infectious Diseases (ECCMID)du 25/04/2015 au 28/04/2015Copenhague, Danemark

ICAAC, 2015du 17/09/2015 au 21/09/2015San Diego, USA

16èmes Journées Nationales d’Infectiologie (JNI)du 10/06/2015 au 12/06/2015Lille, France